PharmaJet
Edit

PharmaJet

https://pharmajet.com/
Last activity: 25.06.2026
Active
Categories: AdTechBodyCareDeliveryHardwareHealthTechMarketMedTechTechnologyWaste
Based in Golden, Colorado, PharmaJet’s mission is worldwide acceptance of PharmaJet Needle-Free devices as a standard of care in the vaccine delivery market. The PharmaJet Stratis® innovative Needle-Free Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines intramuscularly or subcutaneously. In August 2014, the PharmaJet Stratis® Needle-Free Injector was approved for delivery of an influenza vaccine to deliver needle-free flu shots. The PharmaJet Tropis® device for intradermal injections received authorization to apply the CE Mark in May 2016. The PharmaJet Needle-Free Injectors are easy-to-use and eliminate needlestick injuries, needle reuse and cross contamination, and help reduce sharps waste disposal.
Followers
2.51K
Website visits
6.6K /mo.
Mentions
12
Location: United States, Colorado, Golden
Employees: 11-50
Total raised: $5M
Founded date: 2005

Investors 5

Funding Rounds 1

DateSeriesAmountInvestors
05.03.2018-$5M-

Mentions in press and media 12

DateTitleDescription
25.06.2026AI-Designed Universal Coronavirus Vaccine Passes First Human Trial: Cambridge Team Eyes Phase IIBy Mike Gonzales Published: Jun 25 2026, 9:59 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard
19.06.2025Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in HumansHONG KONG, June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration with PharmaJet® to evaluate the ...
11.03.2024Needle-Free Injection System Market is growing at a CAGR of 17.91% from 2024 to 2030 by Exactitude ConsultancyNeedle-Free Injection System market The Exactitude Consultancy Needle-Free Injection System Market Report – Size, Trends, and Forecast 2024-2030 The Needle-Free Injection System market is witnessing significant demand due to its painless an...
13.10.2023米国PharmaJet社への出資について株式会社ダイセル(本社:大阪市北区、代表取締役社長:小河義美、以下 ダイセル)とPharmaJet, Inc.(本社:米国コロラド州、President:Chris Cappello、以下 PharmaJet社)は、本日、戦略的な資本提携を行うことに合意しましたのでご報告いたします。 PharmaJet社は、無針注射器のグローバルリーダーであり、この戦略的資本提携と新会社ダイセルメディカル設立により、医療業界への本格参入を目指します。 PharmaJet社は、医薬品やワク...
14.10.2022Self-Amplifying mRNA Vaccine Receives EUA Nod From Indian RegulatorsTOPSHOT - Women stand in a queue as they wait to receive their vaccine against the Covid-19 ... [+] coronavirus at a primary health centre in Siliguri on August 2, 2021. (Photo by Diptendu DUTTA / AFP) (Photo by DIPTENDU DUTTA/AFP via Getty...
05.03.2018Global health startup PharmaJet with needle-free injectable device close to raising $5MPharmaJet has benefited from global health events, including a movement away from oral polio vaccine, which contains a live, but weakened virus and can actually transmit polio. Meanwhile, greater reliance on an injectable vaccine, which con...
14.09.2012Needleless syringe maker presses on, raising $2.8 million amid U.S. flu vaccine hurdlePharmaJet is the maker of the Stratis system, a needle-free device used to deliver drugs, including vaccines, through the skin. It can deliver 0.5 mL of a drug — the dose for vaccines including hepatitis A and B, poliovirus, seasonal flu, H...
18.11.2011Healthcare investing: 5 underserved medical problemsHere are five medical problems that could stand to receive more investment dollars — and a few of the companies tackling those problems. Hospital readmissions: Rehospitalizations are a widespread and costly problem. A recent report found th...
-Healthcare investing: 5 underserved medical problemsDespite all the talk of an unfavorable IPO market, venture firms fleeing the space and an uncertain regulatory environment, there are still plenty of investment dollars sloshing around in the healthcare industry. Healthcare investment may b...
-Global NGO expands use of PharmaJet for Polio Eradication CampaignsGOLDEN, Colo.--(BUSINESS WIRE)--Mar 9, 2021-- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that a global NGO (Non-governmental organization) has expanded the use of its Tropis ® Needle-free Injectio...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In